EFPIA - NEWSLETTER

Trouble reading this email? View it in your browser


		EFPIA Newsletter 11 September 2025

Prevention, early detection and intervention: how the EU Cardiovascular Health Plan could transform health in Europe

Read more here.

1 in 3 deaths in the EU are due to cardiovascular disease (CVD), with 20% of all premature deaths (before the age of 65) caused by cardiovascular conditions. In addition to the human suffering, cardiovascular disease is estimated to cost the European economy EUR282 billion each year. Prevention, early detection, timely intervention and long-term, person-centred management are essential for improving health outcomes and quality of life for patients, as well as underpinning much needed economic prosperity for Europe.

To support the development of a robust EU CVH Plan, EFPIA and Vaccines Europe have published a position paper setting out detailed proposals for better cardiovascular health. It focuses on key goals in CVH and proposes concrete supportive actions required to turn aspiration into reality.

EFPIA response to European Commission President State of the Union speech
10 September 2025

The State of the Union speech highlights a number of positive and welcome initiatives from the European Commission over... Read more

EFPIA Webinar - Decentralised clinical trials: Turning experience into established practice

The EFPIA Webinar Decentralised clinical trials: Turning experience into established practice explored what it takes to successfully adopt decentralised trial elements. From real-world insights at the clinical site level to high-level policy and patient perspectives, this session showed the opportunities, challenges, and systemic changes needed to scale innovation in clinical research.

Watch the recording here.

Events

EFPIA Life Sciences Week
22 September 2025 (Brussels)

A series of high-level policy discussions on the future of healthcare and innovation in Europe. Read more

How to fight blood cancers with CAR-T cells and big data
01 October 2025 (Online)

Join us online on 1 October at 10:30 for a deep dive into four IHI projects that are revolutionising the fight against... Read more

POLITICO Competitive Europe Summit
01 October 2025 (Brussels, Belgium)

Competitiveness isn’t just a regional concern—it is a race to be ahead in the global pecking order. With China and the... Read more

IHI Brokerage Event 2025
04 November 2025 (Brussels, Belgium)

If you’re interested in future IHI funding opportunities, the IHI Brokerage Event is the ideal place to network and... Read more

What we are reading

Denmark close to wiping out leading cancer-causing HPV strains after vaccine roll-out
On 02 September 2025 (Gavi)

A nationwide study suggests infections with human papillomavirus (HPV) types 16 and 18 have been virtually eliminated... Read more

Scientists are discovering a powerful new way to prevent cancer
On 02 September 2025 (The Economist)

Treatments should encourage healthy cells as well as killing unhealthy ones.

The essential role of vaccines in healthy ageing
On 25 August 2025 (Vaccines Today)

As populations age, vaccines have become one of the most underused tools to protect older adults, not just from infection,... Read more

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu